The Multidisciplinary Research Training Program in Lung Disease is led by Program Director, Theodore Standiford, MD, along with Associate Program Directors, Kevin Flaherty, MD, MS, and Gary Huffnagle, PhD.
Program Director, Theodore Standiford, MD
Theodore Standiford, MD, is a Henry Sewall Professor of Medicine, Professor of Internal Medicine, and Chief of the Division of Pulmonary & Critical Care Medicine. He has had continuous NIH grant funding as Principal Investigator for over 20 years and has served as the Program Director of the University of Michigan SCOR in Acute Lung Injury (2000-2002) and University of Michigan SCCOR in Acute Lung Injury (2003-2009). Dr. Standiford has served as a permanent member of the NIH Lung Biology and Pathology (LBPA) and Lung Cell and Molecular Immunology (LCMI) Study Sections. He served as a member of the American Lung Association Research Fellowship and Career Investigator Award Committee from 2000-2004, and Chair of this committee from 2004-2009. He is an elected member of the American Society for Clinical Investigation (ASCI) and the Association of American Physicians (AAP). Dr. Standiford currently serves as an external consultant for two NIH T32 training programs and an NIH K24 patient-oriented research training program. Dr. Standiford has served as a preceptor for 12 postdoctoral research fellows since 2003, eight of which were supported by this T32 program. Five of his trainees have obtained K-series awards, four have received R-series awards, and one is a Parker B. Francis Fellow. Dr. Standiford’s bibliography lists over 200 peer-reviewed publications. As Chief of the Division of Pulmonary & Critical Care Medicine, Dr. Standiford is responsible for the distribution and utilization of divisional resources at both Michigan Medicine and the VA Ann Arbor Healthcare System.
Associate Program Director, Kevin Flaherty, MD, MS
Kevin Flaherty, MD, MS, is Professor of Internal Medicine in the Division of Pulmonary & Critical Care Medicine. He completed a fellowship in Pulmonary and Critical Care Medicine at the University of Michigan and completed a Masters in Biostatistics and Clinical Study Design from the University of Michigan School of Public Health, training that was supported by our T32 program. Dr. Flaherty has an established scholarly niche in the study and treatment of patients with interstitial lung disease. His research involves retrospective database analyses, translational collaborations, and participation in industry and NIH-sponsored clinical trials. He has served on the NIH-sponsored Idiopathic Pulmonary Fibrosis Network as Co-Chair of the Measurements and Endpoint Committee and was asked to be on the writing committee for two of the three studies performed by the Network. Dr. Flaherty has over 80 peer-reviewed publications and has maintained NIH R01, K24, and contract funding since his initial K23 award. In addition to research, Dr. Flaherty served as mentor or co-mentor for several T32 trainees. He is an active member and immediate past-president of the Michigan Thoracic Society. He served on nominating and program committees, was Chair-elect (2009) and Chair (2010) of the American Thoracic Society Clinical Problems Program Committee as well as chaired the American Thoracic Society Clinical Year in Review Program from 2009-2011. He has also been a member of the University of Michigan’s Institutional Review Board since 2003. Dr. Flaherty bring his expertise and training in clinical medicine and patient-oriented research to lead the Clinical Core section of the Core Curriculum (Tier 1) of this Training Program and works with Dr. Standiford and Dr. Huffnagle in the bi-monthly T32 trainee conferences.
Associate Program Director, Gary Huffnagle, PhD
Gary Huffnagle, PhD is a Nina and Jerry D Luptak Research Professor, Professor of Internal Medicine, Professor of Microbiology and Immunology, and Professor of Molecular, Cellular and Developmental Biology. Dr. Huffnagle has been actively involved in education, training, and research for over 20 years. He is a nationally and internationally recognized researcher, with over 100 peer-reviewed publications, whose expertise is in host-microbe interactions and mucosal immunology, including microbiome-immune system interactions. He has led the efforts to establish a University-wide microbiome research program (University of Michigan Microbiome Research Initiative, UMMRI) to study microbial ecology and host-microbe symbiosis in health and disease, using animal models and clinical samples. Dr. Huffnagle is the co-director of the newly developing Microbial Systems Science Center at the University of Michigan. He is actively involved in various aspects of the NIH Human Microbiome Project (HMP), including participation in a number of workshops. He has served on many standing and ad hoc NIH study sections as a reviewer. Dr. Huffnagle has trained 27 undergraduates, 12 graduate students, and 12 postdoctoral fellows (PhD, MD, and DVM). His former trainees hold positions in medical schools, colleges and industry, including a number that have successfully competed for NIH funding. He is actively involved in the Pulmonary and Critical Care Medicine Fellowship Training Program, as well as the graduate program in Microbiology & Immunology. Dr. Huffnagle is also a co-founder and currently steering committee chair for the interdepartmental undergraduate microbiology major at the University of Michigan. For his educational and training efforts in graduate and undergraduate education, the President and Provost of the University of Michigan recognized Dr. Huffnagle in 2010 with a Faculty Recognition Award. Dr. Huffnagle provides leadership in curriculum development and administration to lead the Mechanisms of Disease curriculum of the Core Curriculum (Tier 1) of this Training Program and works with Dr. Standiford and Dr. Flaherty in the bi-monthly T32 trainee conferences.